Rep. Trone, Sen. Markey Call for State Dept. to Issue Travel Advisory for Mexico Amid Reports of Fentanyl-Laced, Counterfeit Prescription Pills Sold to U.S. Visitors
FOR IMMEDIATE RELEASE
March 13, 2023
Contact: Sasha Galbreath, Sasha.Galbreath@mail.house.gov
Rep. Trone, Sen. Markey Call for State Dept. to Issue Travel Advisory for Mexico Amid Reports of Fentanyl-Laced, Counterfeit Prescription Pills Sold to U.S. Visitors
WASHINGTON, D.C. — Congressman David Trone (D-MD), co-chair of the Commission on Combating Synthetic Opioid Trafficking, and Senator Edward J. Markey (D-MA), a member of the Commission, sent a letter to Secretary of State Antony Blinken today calling on the State Department to issue a travel advisory for travelers to Mexico. The request follows reporting from the Los Angeles Times and independent research from the University of California, Los Angeles showing that pharmacies near tourist locations across Mexico are selling pills – including Oxycodone and Adderall – that contain potentially deadly amounts of fentanyl, methamphetamine, and heroin.
“These adulterated drugs place unsuspecting U.S. tourist customers — some of whom are seeking to avoid high pharmaceutical drug pricing in the United States — at risk of overdose and death,” Congressman Trone and Senator Markey wrote in their letter to Secretary Blinken. “The Los Angeles Times investigation found that 71% of the pills their investigators purchased from Mexican pharmacies were contaminated with powerful drugs such as fentanyl and methamphetamine.”
Congressman Trone and Senator Markey continued, “As an immediate step, the State Department needs to warn Americans traveling to Mexico of the danger they face when purchasing pills from Mexican pharmacies.”
The State Department, through the travel advisories it issues, helps travelers assess the risks of international travel and the steps they should take to ensure their safety abroad.
The U.S. Commission on Combating Synthetic Opioid Trafficking released its final report in February 2022. Its recommendations included reducing demand for fentanyl and other synthetic opioids through a sustained commitment to public health – including more and better access to treatment for opioid use disorder; coordinating drug control efforts across the federal government; disrupting the supply of fentanyl; and collaborating with other countries involved in producing and distributing synthetic opioids.
Congressman David Trone co-founded and co-chairs the 130-member Bipartisan Mental Health and Substance Use Disorder Task Force. He was elected to the House of Representatives in November 2018 to serve the 6th District of Maryland, which includes all or part of Montgomery, Frederick, Washington, Allegany, and Garrett Counties. Trone serves on the Appropriations, Budget, and Joint Economic Committees in the 118th Congress. In Congress, Trone is fighting to make progress on issues that matter to Marylanders, including the mental health and addiction crises, criminal justice reform, and funding for medical research.
Follow Congressman Trone at @RepDavidTrone for updates on Twitter, Facebook, and Instagram.
###
